Research Articles | Page 72 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
One-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab Dec 2020 European Journal of Haematology paroxysmal nocturnal hemoglobinuria (PNH)
Only particular cytogenetic events are related to disease progression in sequential cytogenetic studies in myelodysplastic syndromes. Jun 2013 J BUON myelodysplastic syndromes (MDS)
Optimal positioning of hematopoietic stem cell transplantation for older patients with myelodysplastic syndromes Jan 2013 Curr Opin Hematol myelodysplastic syndromes (MDS)
Optimizing the use of hypomethylating agents in myelodysplastic syndromes: Selecting the candidate, predicting the response, and enhancing the activity Jun 2017 Semin Hematol myelodysplastic syndromes (MDS)
Optimizing the use of hypomethylating agents in myelodysplastic syndromes: Selecting the candidate, predicting the response, and enhancing the activity Sep 2017 Semin Hematol myelodysplastic syndromes (MDS)
Oral Azacitidine (CC-486) for the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia Oct 2015 Oncologist myelodysplastic syndromes (MDS)
Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study Jan 2024 Lancet Hematology myelodysplastic syndromes (MDS)
Oral therapy for myelodysplastic syndromes/neoplasms and acute myeloid leukemia: a revolution in progress Jul 2023 Expert Review of Anticancer Therapies myelodysplastic syndromes (MDS)
Origins of myelodysplastic syndromes after aplastic anemia Sep 2017 Blood aplastic anemia
Outcome of Allogeneic Stem Cell Transplantation for Patients Transformed to MDS or Leukemia from Severe Aplastic Anemia. A report by the MDS subcommittee of the chronic malignancies working party (CMWP) and the severe aplastic anemia working party (WPSAA) Jun 2014 Biol Blood Marrow Transplant aplastic anemia
Share with addtoany.com.